Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14


Region-specific transcriptomic and functional signatures of mononuclear phagocytes in the epididymis.

Battistone MA, Mendelsohn AC, Spallanzani RG, Brown D, Nair AV, Breton S.

Mol Hum Reprod. 2020 Jan 1;26(1):14-29. doi: 10.1093/molehr/gaz059.


Low Doses of CPS49 and Flavopiridol Combination as Potential Treatment for Advanced Prostate Cancer.

Zalazar F, Luca P, Gardner K, Figg WD, Meiss R, Spallanzani RG, Vallecorsa P, Elguero B, Cotignola J, Vazquez E, Siervi A.

Curr Pharm Biotechnol. 2019;20(12):1072. doi: 10.2174/138920102012190919103433.


Novel role of proton-secreting epithelial cells in sperm maturation and mucosal immunity.

Battistone MA, Spallanzani RG, Mendelsohn AC, Capen D, Nair AV, Brown D, Breton S.

J Cell Sci. 2019 Nov 18;133(5). pii: jcs233239. doi: 10.1242/jcs.233239.


Distinct immunocyte-promoting and adipocyte-generating stromal components coordinate adipose tissue immune and metabolic tenors.

Spallanzani RG, Zemmour D, Xiao T, Jayewickreme T, Li C, Bryce PJ, Benoist C, Mathis D.

Sci Immunol. 2019 May 3;4(35). pii: eaaw3658. doi: 10.1126/sciimmunol.aaw3658.


TCR Transgenic Mice Reveal Stepwise, Multi-site Acquisition of the Distinctive Fat-Treg Phenotype.

Li C, DiSpirito JR, Zemmour D, Spallanzani RG, Kuswanto W, Benoist C, Mathis D.

Cell. 2018 Jul 12;174(2):285-299.e12. doi: 10.1016/j.cell.2018.05.004. Epub 2018 Jun 7.


Interleukin (IL)-23 Stimulates IFN-γ Secretion by CD56bright Natural Killer Cells and Enhances IL-18-Driven Dendritic Cells Activation.

Ziblat A, Nuñez SY, Raffo Iraolagoitia XL, Spallanzani RG, Torres NI, Sierra JM, Secchiari F, Domaica CI, Fuertes MB, Zwirner NW.

Front Immunol. 2018 Jan 17;8:1959. doi: 10.3389/fimmu.2017.01959. eCollection 2017.


Complexity of Complement Resistance Factors Expressed by Acinetobacter baumannii Needed for Survival in Human Serum.

Sanchez-Larrayoz AF, Elhosseiny NM, Chevrette MG, Fu Y, Giunta P, Spallanzani RG, Ravi K, Pier GB, Lory S, Maira-Litrán T.

J Immunol. 2017 Oct 15;199(8):2803-2814. doi: 10.4049/jimmunol.1700877. Epub 2017 Aug 30.


Predictive Outcomes for HER2-enriched Cancer Using Growth and Metastasis Signatures Driven By SPARC.

Güttlein LN, Benedetti LG, Fresno C, Spallanzani RG, Mansilla SF, Rotondaro C, Raffo Iraolagoitia XL, Salvatierra E, Bravo AI, Fernández EA, Gottifredi V, Zwirner NW, Llera AS, Podhajcer OL.

Mol Cancer Res. 2017 Mar;15(3):304-316. doi: 10.1158/1541-7786.MCR-16-0243-T. Epub 2016 Dec 28.


NK Cells Restrain Spontaneous Antitumor CD8+ T Cell Priming through PD-1/PD-L1 Interactions with Dendritic Cells.

Iraolagoitia XL, Spallanzani RG, Torres NI, Araya RE, Ziblat A, Domaica CI, Sierra JM, Nuñez SY, Secchiari F, Gajewski TF, Zwirner NW, Fuertes MB.

J Immunol. 2016 Aug 1;197(3):953-61. doi: 10.4049/jimmunol.1502291. Epub 2016 Jun 24.


Regulatory Dendritic Cells Restrain NK Cell IFN-γ Production through Mechanisms Involving NKp46, IL-10, and MHC Class I-Specific Inhibitory Receptors.

Spallanzani RG, Torres NI, Avila DE, Ziblat A, Iraolagoitia XL, Rossi LE, Domaica CI, Fuertes MB, Rabinovich GA, Zwirner NW.

J Immunol. 2015 Sep 1;195(5):2141-8. doi: 10.4049/jimmunol.1403161. Epub 2015 Jul 31.


Low doses of CPS49 and flavopiridol combination as potential treatment for advanced prostate cancer.

Zalazar F, De Luca P, Gardner K, Figg WD, Meiss R, Spallanzani RG, Vallecorsa P, Elguero B, Cotignola J, Vazquez E, De Siervi A.

Curr Pharm Biotechnol. 2015;16(6):553-63. Erratum in: Curr Pharm Biotechnol. 2019;20(12):1072.


IL-27 stimulates human NK-cell effector functions and primes NK cells for IL-18 responsiveness.

Ziblat A, Domaica CI, Spallanzani RG, Iraolagoitia XL, Rossi LE, Avila DE, Torres NI, Fuertes MB, Zwirner NW.

Eur J Immunol. 2015 Jan;45(1):192-202. doi: 10.1002/eji.201444699. Epub 2014 Dec 2.


Expansion of CD11b(+)Ly6G (+)Ly6C (int) cells driven by medroxyprogesterone acetate in mice bearing breast tumors restrains NK cell effector functions.

Spallanzani RG, Dalotto-Moreno T, Raffo Iraolagoitia XL, Ziblat A, Domaica CI, Avila DE, Rossi LE, Fuertes MB, Battistone MA, Rabinovich GA, Salatino M, Zwirner NW.

Cancer Immunol Immunother. 2013 Dec;62(12):1781-95. doi: 10.1007/s00262-013-1483-x. Epub 2013 Oct 11.


Histone deacetylase inhibitors impair NK cell viability and effector functions through inhibition of activation and receptor expression.

Rossi LE, Avila DE, Spallanzani RG, Ziblat A, Fuertes MB, Lapyckyj L, Croci DO, Rabinovich GA, Domaica CI, Zwirner NW.

J Leukoc Biol. 2012 Feb;91(2):321-31. doi: 10.1189/jlb.0711339. Epub 2011 Nov 28.


Supplemental Content

Loading ...
Support Center